Xigao Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xigao Cheng has a total of 228 co-authors. Here are the top co-authors by number of shared publications:
Tianlong Wu
Department of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China
37 shared publicationsXinxin Miao
Department of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006 Nanchang, Jiangxi, China
27 shared publicationsJian Zhang
21 shared publicationsJinghong Yuan
Department of Orthopaedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, 330006 Nanchang, Jiangxi, China
21 shared publicationsJingyu Jia
Department of Orthopedics The Second Affiliated Hospital Jiangxi Medical College Nanchang University Nanchang 330006 P. R. China
20 shared publicationsRui Ding
Jiangxi Provincial Key Laboratory of Spine and Spinal Cord Disease, Nanchang, China
16 shared publications
Latest Publications
- Open Access
Multi-Cohort Transcriptomic and Single-Cell Analyses Identify Six Directionally Concordant Blood-Transcriptomic Signals Associated with Low Bone Mineral Density and Alzheimer’s Disease
Background/Objectives: Alzheimer’s disease (AD) and low bone mineral density (BMD) frequently coexist, but whether they show reproducible concordant blood-transcriptomic signals remains unclear. We conducted a retrospective computational study to identify cross-phenotype expression patterns and explore their biological context. Methods: One low-versus-high-BMD monocyte cohort and two AD whole-blood cohorts were used to derive six directionally concordant candidate genes. Repeated nested cross-validation provided internal predictive characterization, followed by independent AD evaluation in GSE140829 and exploratory osteoporosis evaluation in GSE56116. Gene–immune analyses, leukocyte-composition sensitivity analyses, Mendelian randomization, WGCNA, donor-aware single-cell analysis, virtual knockout, and direction-constrained compound prioritization were used as complementary exploratory analyses. Results: The candidates were FOXO3, IL1R2, WWP1, PDPK1, DPP8, and TSNAX. In GSE140829, all six retained their discovery directions, but only IL1R2 passed candidate-level FDR correction; the six-gene and robust-core scores showed modest discrimination (AUCs 0.601 and 0.610). Adjustment for inferred leukocyte composition attenuated the IL1R2 effect, but it remained FDR-supported using both CIBERSORT-derived (FDR = 0.00483) and xCell2-derived (FDR = 0.0140) composition covariates. Mendelian randomization yielded no FDR-supported causal estimate. Network, single-cell, virtual-knockout, and compound-prioritization results were exploratory and hypothesis-generating. Conclusions: Six blood-transcriptomic signals showed directional concordance between low BMD and AD, with IL1R2 providing the strongest independent AD evidence after leukocyte-composition sensitivity analyses. These findings do not establish a disease-specific shared causal mechanism, a clinically useful biomarker, or a therapeutic strategy. Prospective, protein-level, and functional validation is required before clinical or therapeutic application can be considered.
Open AccessMulti-Cohort Transcriptomic and Single-Cell Analyses Identify Six Directionally Concordant Blood-Transcriptomic Signals Associated with Low Bone Mineral Density and Alzheimer’s Disease
Background/Objectives: Alzheimer’s disease (AD) and low bone mineral density (BMD) frequently coexist, but whether they show reproducible concordant blood-transcriptomic signals remains unclear. We conducted a retrospective computational study to identify cross-phenotype expression patterns and explore their biological context. Methods: One low-versus-high-BMD monocyte cohort and two AD whole-blood cohorts were used to derive six directionally concordant candidate genes. Repeated nested cross-validation provided internal predictive characterization, followed by independent AD evaluation in GSE140829 and exploratory osteoporosis evaluation in GSE56116. Gene–immune analyses, leukocyte-composition sensitivity analyses, Mendelian randomization, WGCNA, donor-aware single-cell analysis, virtual knockout, and direction-constrained compound prioritization were used as complementary exploratory analyses. Results: The candidates were FOXO3, IL1R2, WWP1, PDPK1, DPP8, and TSNAX. In GSE140829, all six retained their discovery directions, but only IL1R2 passed candidate-level FDR correction; the six-gene and robust-core scores showed modest discrimination (AUCs 0.601 and 0.610). Adjustment for inferred leukocyte composition attenuated the IL1R2 effect, but it remained FDR-supported using both CIBERSORT-derived (FDR = 0.00483) and xCell2-derived (FDR = 0.0140) composition covariates. Mendelian randomization yielded no FDR-supported causal estimate. Network, single-cell, virtual-knockout, and compound-prioritization results were exploratory and hypothesis-generating. Conclusions: Six blood-transcriptomic signals showed directional concordance between low BMD and AD, with IL1R2 providing the strongest independent AD evidence after leukocyte-composition sensitivity analyses. These findings do not establish a disease-specific shared causal mechanism, a clinically useful biomarker, or a therapeutic strategy. Prospective, protein-level, and functional validation is required before clinical or therapeutic application can be considered.
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 645-661
Spatiotemporally adaptive metal-gas nanotherapy: Acid-triggered cascade release for osteoporosis treatment
The treatment of osteoporosis remains a critical challenge due to the limitations of current therapies in simultaneously restoring homeostasis of bone metabolism and modulating the chronic inflammation of bone microenvironment. While the acidic microenvironment greatly exacerbates bone resorption, it also lays the foundation for the application of responsive therapeutic nanoplatforms. Herein, inspired by the rocket-like responsive cascade release principle-defined by a “booster-payload” mechanism, in which a metal ion-doped mesoporous silica shell serves as an early-release booster and a calcium sulfide core acts as a sustained-release payload-a bone-targeted nanoplatform (CSM3P) was developed. This platform integrates calcium sulfide nanoparticles with magnesium/manganese-doped mesoporous silica for bone targeting. It leverages the pathological acidic microenvironment of osteoporosis to enable stimuli-responsive and stepwise release of multiple mineral ions (Mg2+/Mn2+/Ca2+) and hydrogen sulfide (H2S), coordinates bone regeneration and regulation of the osteoimmunological microenvironment and thereby achieves metal-gas targeted therapy for osteoporosis. This acidic responsive and sequential ion/gas release model establishes a self-reinforcing therapeutic cycle, where the pathological acidity itself drives a synergistic and adaptive treatment regimen. Both in vitro and in vivo evaluations demonstrate the superior efficacy of CSM3P in ameliorating the inflammatory bone microenvironment and rebalancing bone remodeling. This work offers a novel paradigm for intelligent, feedback-driven nanotherapy against osteoporosis and other microenvironment-associated diseases.
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 645-661
Open AccessSpatiotemporally adaptive metal-gas nanotherapy: Acid-triggered cascade release for osteoporosis treatment
The treatment of osteoporosis remains a critical challenge due to the limitations of current therapies in simultaneously restoring homeostasis of bone metabolism and modulating the chronic inflammation of bone microenvironment. While the acidic microenvironment greatly exacerbates bone resorption, it also lays the foundation for the application of responsive therapeutic nanoplatforms. Herein, inspired by the rocket-like responsive cascade release principle-defined by a “booster-payload” mechanism, in which a metal ion-doped mesoporous silica shell serves as an early-release booster and a calcium sulfide core acts as a sustained-release payload-a bone-targeted nanoplatform (CSM3P) was developed. This platform integrates calcium sulfide nanoparticles with magnesium/manganese-doped mesoporous silica for bone targeting. It leverages the pathological acidic microenvironment of osteoporosis to enable stimuli-responsive and stepwise release of multiple mineral ions (Mg2+/Mn2+/Ca2+) and hydrogen sulfide (H2S), coordinates bone regeneration and regulation of the osteoimmunological microenvironment and thereby achieves metal-gas targeted therapy for osteoporosis. This acidic responsive and sequential ion/gas release model establishes a self-reinforcing therapeutic cycle, where the pathological acidity itself drives a synergistic and adaptive treatment regimen. Both in vitro and in vivo evaluations demonstrate the superior efficacy of CSM3P in ameliorating the inflammatory bone microenvironment and rebalancing bone remodeling. This work offers a novel paradigm for intelligent, feedback-driven nanotherapy against osteoporosis and other microenvironment-associated diseases.
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 141-165
Smart biophysical cue-based strategies and materials for intervertebral disc degeneration therapy
Low back pain (LBP) is the leading cause of non-fatal disability globally, significantly affecting quality of life and imposing an immense socioeconomic burden. Intervertebral disc degeneration (IVDD) is a major cause of LBP. Although advances in biomaterials and drug delivery have provided new therapeutic options, their efficacy remains limited by invasive delivery approaches and the spatiotemporal dynamic changes in the microenvironment during treatment. In recent years, smart biophysical cue-based strategies—represented by electrical, magnetic, photo, ultrasonic, and mechanical cues—have offered breakthrough noninvasive or minimally invasive approaches for IVDD intervention. Such cues can act directly or indirectly on disc tissues, modulating oxidative stress signaling pathways, optimizing the inflammatory microenvironment, and influencing cellular behavior and extracellular matrix metabolism, thereby delaying or even reversing the degenerative process. These modalities possess highly controllable and precise regulatory potential for tissue repair and can synergize with intelligent biomaterials, drug delivery systems, and other therapeutic strategies to achieve multi-dimensional and multi-targeted regulation. Current research in this field has largely concentrated on isolated biophysical cues or individual material systems, resulting in fragmented advances and a lack of systematic cross-comparison, which limits their translational relevance for precise clinical intervention. This review goes beyond single-cue perspectives to provide a comprehensive and comparative integration of multiple biophysical cue-based strategies and materials within the IVDD field, systematically elucidating their mechanisms of action and developmental trajectories. Moreover, from an interdisciplinary perspective, this review provides new theoretical foundations and directions for precision therapy in IVDD.
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 141-165
Open AccessSmart biophysical cue-based strategies and materials for intervertebral disc degeneration therapy
Low back pain (LBP) is the leading cause of non-fatal disability globally, significantly affecting quality of life and imposing an immense socioeconomic burden. Intervertebral disc degeneration (IVDD) is a major cause of LBP. Although advances in biomaterials and drug delivery have provided new therapeutic options, their efficacy remains limited by invasive delivery approaches and the spatiotemporal dynamic changes in the microenvironment during treatment. In recent years, smart biophysical cue-based strategies—represented by electrical, magnetic, photo, ultrasonic, and mechanical cues—have offered breakthrough noninvasive or minimally invasive approaches for IVDD intervention. Such cues can act directly or indirectly on disc tissues, modulating oxidative stress signaling pathways, optimizing the inflammatory microenvironment, and influencing cellular behavior and extracellular matrix metabolism, thereby delaying or even reversing the degenerative process. These modalities possess highly controllable and precise regulatory potential for tissue repair and can synergize with intelligent biomaterials, drug delivery systems, and other therapeutic strategies to achieve multi-dimensional and multi-targeted regulation. Current research in this field has largely concentrated on isolated biophysical cues or individual material systems, resulting in fragmented advances and a lack of systematic cross-comparison, which limits their translational relevance for precise clinical intervention. This review goes beyond single-cue perspectives to provide a comprehensive and comparative integration of multiple biophysical cue-based strategies and materials within the IVDD field, systematically elucidating their mechanisms of action and developmental trajectories. Moreover, from an interdisciplinary perspective, this review provides new theoretical foundations and directions for precision therapy in IVDD.
- Open Access
- 27 July 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (7)
Transcriptomic and Single-Cell Analyses Reveal a Prognostic Mitochondria- and Immunity-Related Risk Signature in Osteosarcoma
Background:While mitochondrial dysfunction and immune cell dysregulation have been established as important contributors to the pathogenesis of osteosarcoma (OS), the prognostic value of mitochondria-related genes (MRGs) and immune-related genes (IRGs) in OS remains poorly understood.Methods:Data were obtained from public databases. Differentially expressed genes (DEGs) and key module genes were identified viadifferential expression analysis and weighted gene co-expression network analysis, respectively. Candidate genes of interest were identified by intersecting key module genes, DEGs, MRGs, and IRGs. Then, candidate genes were screened using regression analysis and proportional hazards assumption testing to identify prognostic genes. A risk model was then constructed in the TARGET-OS dataset and validated in GSE16091. Independent prognostic, immune infiltration, and gene expression analyses were conducted. In addition, single-cell analysis was performed to identify key cell populations, and pseudotime analysis as well as cell communication network construction were carried out. Finally, the expression patterns of selected prognostic genes were additionally validated via reverse transcription quantitative polymerase chain reaction (RT-qPCR), and the functional role of protein kinase Cα (PRKCA) in osteosarcoma cell proliferation, migration, and invasion was evaluated in vitro.Results:Glutathione S-transferase Pi-1 (GSTP1), catalase (CAT), TNFSF10, and PRKCA were identified as mitochondria- and immunity-related prognostic genes in OS and were used to construct a risk model. The risk model was able to effectively predict the survival of patients with OS. A nomogram based on the identified prognostic genes additionally exhibited excellent performance when predicting OS patient survival. Significant differences in the abundance of 14 immune cell types and 8 immune checkpoint molecules were noted between the high-risk and low-risk groups. Single-cell analyses were then conducted to annotate 10 cell types, and M1 macrophages were identified as a potentially relevant cell population in the OS microenvironment. During M1 macrophage differentiation, initial reductions in CAT and PRKCA expression were noted, followed by subsequent increases and final decreases. In contrast, the expression of GSTP1 and TNFSF10 in these cells first rose and then declined. Furthermore, PRKCA was selected for further in vitro analyses, which revealed that it can enhance the invasion, migration, and proliferation of OS cells.Conclusion:This study identified GSTP1, CAT, TNFSF10, and PRKCA as prognostic genes associated with mitochondrial and immune function in OS, with in vitro evidence providing direct support for the potential functional role of PRKCA in OS progression. These findings highlight a new avenue for predicting clinical prognosis in OS and may provide a basis for future studies of putative therapeutic targets.
- 27 July 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (7)
Open AccessTranscriptomic and Single-Cell Analyses Reveal a Prognostic Mitochondria- and Immunity-Related Risk Signature in Osteosarcoma
Background:While mitochondrial dysfunction and immune cell dysregulation have been established as important contributors to the pathogenesis of osteosarcoma (OS), the prognostic value of mitochondria-related genes (MRGs) and immune-related genes (IRGs) in OS remains poorly understood.Methods:Data were obtained from public databases. Differentially expressed genes (DEGs) and key module genes were identified viadifferential expression analysis and weighted gene co-expression network analysis, respectively. Candidate genes of interest were identified by intersecting key module genes, DEGs, MRGs, and IRGs. Then, candidate genes were screened using regression analysis and proportional hazards assumption testing to identify prognostic genes. A risk model was then constructed in the TARGET-OS dataset and validated in GSE16091. Independent prognostic, immune infiltration, and gene expression analyses were conducted. In addition, single-cell analysis was performed to identify key cell populations, and pseudotime analysis as well as cell communication network construction were carried out. Finally, the expression patterns of selected prognostic genes were additionally validated via reverse transcription quantitative polymerase chain reaction (RT-qPCR), and the functional role of protein kinase Cα (PRKCA) in osteosarcoma cell proliferation, migration, and invasion was evaluated in vitro.Results:Glutathione S-transferase Pi-1 (GSTP1), catalase (CAT), TNFSF10, and PRKCA were identified as mitochondria- and immunity-related prognostic genes in OS and were used to construct a risk model. The risk model was able to effectively predict the survival of patients with OS. A nomogram based on the identified prognostic genes additionally exhibited excellent performance when predicting OS patient survival. Significant differences in the abundance of 14 immune cell types and 8 immune checkpoint molecules were noted between the high-risk and low-risk groups. Single-cell analyses were then conducted to annotate 10 cell types, and M1 macrophages were identified as a potentially relevant cell population in the OS microenvironment. During M1 macrophage differentiation, initial reductions in CAT and PRKCA expression were noted, followed by subsequent increases and final decreases. In contrast, the expression of GSTP1 and TNFSF10 in these cells first rose and then declined. Furthermore, PRKCA was selected for further in vitro analyses, which revealed that it can enhance the invasion, migration, and proliferation of OS cells.Conclusion:This study identified GSTP1, CAT, TNFSF10, and PRKCA as prognostic genes associated with mitochondrial and immune function in OS, with in vitro evidence providing direct support for the potential functional role of PRKCA in OS progression. These findings highlight a new avenue for predicting clinical prognosis in OS and may provide a basis for future studies of putative therapeutic targets.
- Open Access
- 22 May 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1825301
Comparative outcomes of arthroscopy-assisted uniportal spinal surgery vs. unilateral biportal endoscopy for adjacent two-segment lumbar disc herniation: a retrospective cohort study
Purpose: To compare the clinical efficacy and perioperative outcomes of arthroscopy-assisted uniportal spinal surgery (AUSS) and unilateral biportal endoscopy (UBE) for the treatment of adjacent two-segment lumbar disc herniation (AT-LDH). Methods: In this retrospective cohort study, we analyzed the data of 59 patients with AT-LDH admitted to our department between January 2020 and May 2025. Of these, 33 patients underwent AUSS and 26 underwent UBE. The primary outcome measures were the visual analog scale (VAS) for low back and leg pain and Oswestry disability index (ODI). Secondary outcomes included operative time, number of intraoperative fluoroscopies, incision length, length of hospital stay, perioperative hemoglobin change, complications, facet joint preservation, and serum inflammatory markers. Results: Both the AUSS and UBE groups exhibited significant postoperative improvements in VAS and ODI compared with baseline ( p < 0.05). No significant between-group differences in clinical efficacy were observed at any time point ( p > 0.05). The excellent-to-good rates were 87.9% for AUSS and 88.5% for UBE. No significant between-group differences in complication and facet joint preservation rates were found (AUSS: 6.1% vs. UBE: 7.7% and AUSS: 81.6% vs. UBE: 83.2%, respectively). However, the AUSS group showed shorter incision length and operative time, fewer fluoroscopic exposures, smaller postoperative hemoglobin decreases, and lower levels of inflammatory markers on postoperative day 3 (all p < 0.05). Conclusion: Both AUSS and UBE provided satisfactory short-term clinical outcomes for AT-LDH. AUSS offers advantages of reduced invasiveness, greater surgical efficiency, and lower inflammatory response, supporting its broader clinical application.
- 22 May 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1825301
Open AccessComparative outcomes of arthroscopy-assisted uniportal spinal surgery vs. unilateral biportal endoscopy for adjacent two-segment lumbar disc herniation: a retrospective cohort study
Purpose: To compare the clinical efficacy and perioperative outcomes of arthroscopy-assisted uniportal spinal surgery (AUSS) and unilateral biportal endoscopy (UBE) for the treatment of adjacent two-segment lumbar disc herniation (AT-LDH). Methods: In this retrospective cohort study, we analyzed the data of 59 patients with AT-LDH admitted to our department between January 2020 and May 2025. Of these, 33 patients underwent AUSS and 26 underwent UBE. The primary outcome measures were the visual analog scale (VAS) for low back and leg pain and Oswestry disability index (ODI). Secondary outcomes included operative time, number of intraoperative fluoroscopies, incision length, length of hospital stay, perioperative hemoglobin change, complications, facet joint preservation, and serum inflammatory markers. Results: Both the AUSS and UBE groups exhibited significant postoperative improvements in VAS and ODI compared with baseline ( p < 0.05). No significant between-group differences in clinical efficacy were observed at any time point ( p > 0.05). The excellent-to-good rates were 87.9% for AUSS and 88.5% for UBE. No significant between-group differences in complication and facet joint preservation rates were found (AUSS: 6.1% vs. UBE: 7.7% and AUSS: 81.6% vs. UBE: 83.2%, respectively). However, the AUSS group showed shorter incision length and operative time, fewer fluoroscopic exposures, smaller postoperative hemoglobin decreases, and lower levels of inflammatory markers on postoperative day 3 (all p < 0.05). Conclusion: Both AUSS and UBE provided satisfactory short-term clinical outcomes for AT-LDH. AUSS offers advantages of reduced invasiveness, greater surgical efficiency, and lower inflammatory response, supporting its broader clinical application.
- Open Access
- 20 April 2026
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 17 (1)
TGF-β/SMAD signaling maintains nucleus pulposus stem cell quiescence to protect against oxidative injury in intervertebral disc degeneration
Intervertebral disc degeneration (IVDD) is characterized by progressive nucleus pulposus cell loss and extracellular matrix degradation, in which persisten
- 20 April 2026
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 17 (1)
Open AccessTGF-β/SMAD signaling maintains nucleus pulposus stem cell quiescence to protect against oxidative injury in intervertebral disc degeneration
Intervertebral disc degeneration (IVDD) is characterized by progressive nucleus pulposus cell loss and extracellular matrix degradation, in which persisten
- Open Access
- 17 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
METTL14 regulate LRIG1 expression via m6A to affect nucleus pulposus cell senescence in intervertebral disc degeneration
Intervertebral disc degeneration (IVDD) is a major cause of chronic low back pain and disability, but its molecular mechanisms are not fully understood. Recent studies highlight the role of m6A RNA methylation in cellular senescence and extracellular matrix regulation. This study explores the role of METTL14, a key m6A “writer” in regulating LRIG1 expression and its involvement in IVDD pathogenesis. METTL14 expression was evaluated in nucleus pulposus (NP) tissues from IVDD patients at different degeneration stages using immunohistochemistry. In vitro experiments were conducted with METTL14 knockdown and TNF-α-induced cellular degeneration in NP cells. The effects on cellular senescence markers, ECM components, and m6A RNA methylation were examined. m6A RNA immunoprecipitation was employed to assess m6A modification levels. Bioinformatics tools predicted potential m6A sites on LRIG1 mRNA, which were further validated by luciferase reporter assays. METTL14 expression was significantly upregulated in NP tissues from patients with severe IVDD. METTL14 knockdown in NP cells led to reduced m6A enrichment on LRIG1 mRNA, destabilizing LRIG1 transcripts and increasing cellular senescence marker P21. TNF-α stimulation further induced METTL14 expression, exacerbated ECM degradation, and accelerated cellular senescence. Restoration of LRIG1 expression through overexpression mitigated the degenerative changes caused by METTL14 knockdown. Luciferase assays confirmed that METTL14 regulates LRIG1 mRNA stability via specific m6A sites, establishing a METTL14-LRIG1 axis in cellular senescence. This study identifies METTL14 as a critical regulator of LRIG1-mediated ECM stability and cellular senescence in IVDD pathogenesis. The METTL14-LRIG1 axis, driven by m6A modifications, provides new mechanistic insights into the inflammatory and degenerative processes underlying IVDD. Targeting METTL14 or the associated m6A pathway may offer novel therapeutic strategies for IVDD.
- 17 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessMETTL14 regulate LRIG1 expression via m6A to affect nucleus pulposus cell senescence in intervertebral disc degeneration
Intervertebral disc degeneration (IVDD) is a major cause of chronic low back pain and disability, but its molecular mechanisms are not fully understood. Recent studies highlight the role of m6A RNA methylation in cellular senescence and extracellular matrix regulation. This study explores the role of METTL14, a key m6A “writer” in regulating LRIG1 expression and its involvement in IVDD pathogenesis. METTL14 expression was evaluated in nucleus pulposus (NP) tissues from IVDD patients at different degeneration stages using immunohistochemistry. In vitro experiments were conducted with METTL14 knockdown and TNF-α-induced cellular degeneration in NP cells. The effects on cellular senescence markers, ECM components, and m6A RNA methylation were examined. m6A RNA immunoprecipitation was employed to assess m6A modification levels. Bioinformatics tools predicted potential m6A sites on LRIG1 mRNA, which were further validated by luciferase reporter assays. METTL14 expression was significantly upregulated in NP tissues from patients with severe IVDD. METTL14 knockdown in NP cells led to reduced m6A enrichment on LRIG1 mRNA, destabilizing LRIG1 transcripts and increasing cellular senescence marker P21. TNF-α stimulation further induced METTL14 expression, exacerbated ECM degradation, and accelerated cellular senescence. Restoration of LRIG1 expression through overexpression mitigated the degenerative changes caused by METTL14 knockdown. Luciferase assays confirmed that METTL14 regulates LRIG1 mRNA stability via specific m6A sites, establishing a METTL14-LRIG1 axis in cellular senescence. This study identifies METTL14 as a critical regulator of LRIG1-mediated ECM stability and cellular senescence in IVDD pathogenesis. The METTL14-LRIG1 axis, driven by m6A modifications, provides new mechanistic insights into the inflammatory and degenerative processes underlying IVDD. Targeting METTL14 or the associated m6A pathway may offer novel therapeutic strategies for IVDD.
- Open Access
- 23 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (4) , e47252
MIS-TLIF revision surgery for postoperative interbody fusion cage migration via contralateral intervertebral foramen approach: A case report
Rationale: Minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) is widely applied for lumbar spine disorders due to reduced surgical trauma and faster recovery. However, postoperative interbody fusion cage migration remains a challenging complication. This report introduces a contralateral intervertebral foramen revision strategy as an alternative solution to correct cage migration without removing the original cage. Patient concerns: A 55-year-old Asian female presented with progressive lower back pain, radiating leg pain, and limited mobility 5 weeks after MIS-TLIF. Symptoms significantly affected daily activities and were consistent with neurological compression. Diagnoses: Postoperative cage migration with associated nerve compression was confirmed by physical examination and imaging studies, including X-ray, computed tomography, and magnetic resonance imaging. Interventions: A revision MIS-TLIF procedure was performed via the contralateral intervertebral foramen. The migrated cage was repositioned using the original cage handle and Kirschner wire, and an additional interbody cage was implanted to enhance segmental stability. This approach avoided removing the original cage and minimized anatomical disruption. Outcomes: Neurological symptoms improved immediately after surgery, and postoperative imaging confirmed satisfactory cage correction and stabilization. At the 1-year follow-up, the patient reported no recurrent discomfort, and computed tomography imaging demonstrated stable cage position and interbody fusion. Lessons: Contralateral intervertebral foramen access in MIS-TLIF revision surgery offers a minimally invasive alternative for cage migration management, avoiding the need for cage removal and reducing operative trauma. This technique may provide a viable option for similar revision scenarios requiring neural decompression and cage repositioning.
- 23 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (4) , e47252
Open AccessMIS-TLIF revision surgery for postoperative interbody fusion cage migration via contralateral intervertebral foramen approach: A case report
Rationale: Minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) is widely applied for lumbar spine disorders due to reduced surgical trauma and faster recovery. However, postoperative interbody fusion cage migration remains a challenging complication. This report introduces a contralateral intervertebral foramen revision strategy as an alternative solution to correct cage migration without removing the original cage. Patient concerns: A 55-year-old Asian female presented with progressive lower back pain, radiating leg pain, and limited mobility 5 weeks after MIS-TLIF. Symptoms significantly affected daily activities and were consistent with neurological compression. Diagnoses: Postoperative cage migration with associated nerve compression was confirmed by physical examination and imaging studies, including X-ray, computed tomography, and magnetic resonance imaging. Interventions: A revision MIS-TLIF procedure was performed via the contralateral intervertebral foramen. The migrated cage was repositioned using the original cage handle and Kirschner wire, and an additional interbody cage was implanted to enhance segmental stability. This approach avoided removing the original cage and minimized anatomical disruption. Outcomes: Neurological symptoms improved immediately after surgery, and postoperative imaging confirmed satisfactory cage correction and stabilization. At the 1-year follow-up, the patient reported no recurrent discomfort, and computed tomography imaging demonstrated stable cage position and interbody fusion. Lessons: Contralateral intervertebral foramen access in MIS-TLIF revision surgery offers a minimally invasive alternative for cage migration management, avoiding the need for cage removal and reducing operative trauma. This technique may provide a viable option for similar revision scenarios requiring neural decompression and cage repositioning.
- Open Access
- 19 January 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102825
Ultrasound-responsive CPS piezoelectric hydrogel synergistically repairs annulus fibrosus defects through immune reprogramming and cell recruitment
- 19 January 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102825
Open AccessUltrasound-responsive CPS piezoelectric hydrogel synergistically repairs annulus fibrosus defects through immune reprogramming and cell recruitment
- 5 January 2026
- Published by Elsevier in Journal of Orthopaedics
- Vol. 74, 195-204
METTL14 regulate LRIG1 expression via m6A to affect nucleus pulposus cell senescence in intervertebral disc degeneration
- 5 January 2026
- Published by Elsevier in Journal of Orthopaedics
- Vol. 74, 195-204
METTL14 regulate LRIG1 expression via m6A to affect nucleus pulposus cell senescence in intervertebral disc degeneration